NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kookmin Bio Co., Ltd.

Kookmin Bio Co., Ltd.

Private
JeonjuHealthcare & Life Scienceshttps://kmbio.co.kr/ko/

Last Round

Series B

Nov 20, 2024

Total Funding Raised

$4.58M

Company Overview

Kookmin Bio Co., Ltd. is a biotechnology company that researches and develops bio-based food and pharmaceutical ingredients and microbiome-based new drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Drug Discovery, Clinical Trials, Sports & Fitness

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

postbioticsmicrobiome modulationfunctional foodsnutraceuticalssarcopenia treatmentobesity treatmentmicrobiome therapeuticsdrug discoverygut healthB2B ingredientsfermentation technologybiopharmaKorean fermented foodsclinical trialshealth functional foodsGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kookmin Bio Co., Ltd. Comparables

Compare Kookmin Bio Co., Ltd. with similar companies based on industry and business-model similarity.

Kookmin Bio Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Kookmin Bio Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 20, 2024
Series AMay 20, 2022
Pre SeedNov 19, 2021

Kookmin Bio Co., Ltd. Investors

Notable investors and investment history

Kookmin Bio Co., Ltd. investors
InvestorRounds
Korea Alternative Asset ManagementSeries A, Series B
K-Ground VenturesSeries B
Kookmin University Technology Holding Co., Ltd.Series A
New Paradigm InvestmentSeries A, Series B, Pre Seed
Industrial Bank of KoreaSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 20, 2024

    $3M round led by New Paradigm Investment.

  • May 20, 2022

    $1.58M round led by New Paradigm Investment.

Kookmin Bio Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kookmin Bio Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kookmin Bio Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersJeonju
Year Founded2019
Last FundingNov 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.